Luken Investment Analytics, LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.

Quarter-by-quarter ownership
Luken Investment Analytics, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2023$3,571
+19.2%
500.0%0.00%0.0%
Q3 2023$2,996
-58.4%
50
-50.0%
0.00%
-50.0%
Q2 2023$7,210
-2.0%
1000.0%0.00%0.0%
Q1 2023$7,356
+10.1%
1000.0%0.00%0.0%
Q4 2022$6,680
-33.2%
1000.0%0.00%
-42.9%
Q4 2020$10,0001000.01%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
KNOTT DAVID M 1,199,766$130,078,630,00035.65%
CARDINAL CAPITAL MANAGEMENT LLC /CT 852,053$92,380,0005.34%
OBERWEIS ASSET MANAGEMENT INC/ 101,127$10,964,0003.08%
Timpani Capital Management LLC 68,160$7,390,0003.00%
ASHFORD CAPITAL MANAGEMENT INC 103,420$11,213,0002.64%
First Light Asset Management, LLC 56,818$6,160,0002.58%
Conestoga Capital Advisors, LLC 286,162$31,026,0002.51%
OAK RIDGE INVESTMENTS LLC 955,599$103,606,0002.48%
RK Capital 127,983$13,876,0002.42%
Nichols Asset Management LLC 93,170$10,101,0002.20%
View complete list of LIGAND PHARMACEUTICALS INC shareholders